June 8, Tuesday, 2021(1:30 p.m.) Newsline

1. The U.S. Food and Drug Administration has approved a new medication for Alzheimer’s disease. Aducanumab is the first new drug for the disease in 18 years. U.S. company Biogen and Japanese firm Eisai developed the drug. It targets plaques in the brain that researchers believe can affect cognition. Aducanumab is the firs medication to tackle the disease process rather than just treating symptoms of dementia.
2.U.S. President Joe Biden is traveling to Europe for meetings with political and military leaders. It is his first trip abroad since becoming president. Biden will first meet with G7 leaders in Cornwall, England. They will try to formulate a plan to end the pandemic. They will also talk about ways to support developing nations and counteract the influence of China. 3. Peru’s two presidential candidates are in a close race as vote counting continues following the runoff election on Sunday. The next president will face the task of rebuilding Peru’s economy and medical system, both damaged by the coronavirus pandemic.